Brought to you by 
Arachnova, Sosei partner on incontinence candidate
24 Mar 2004
Executive Summary
Sosei (private Japanese drug reprofiler) has partnered with Arachnova Therapeutics Ltd. (employs therapeutic switching methodology to find new uses for existing late preclinical/early clinical drug candidates) on development of AA10020/SOU001 for stress urinary incontinence (SUI).
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com